Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
; 4(10): 101212, 2023 10 17.
Article
in En
| MEDLINE
| ID: mdl-37774704
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rhabdomyosarcoma
/
Receptors, Chimeric Antigen
Type of study:
Prognostic_studies
Limits:
Animals
/
Child
/
Humans
Language:
En
Journal:
Cell Rep Med
Year:
2023
Type:
Article
Affiliation country:
United States